275 related articles for article (PubMed ID: 31691827)
1. Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea.
Malhotra A; Shapiro C; Pepin JL; Hedner J; Ahmed M; Foldvary-Schaefer N; Strollo PJ; Mayer G; Sarmiento K; Baladi M; Chandler P; Lee L; Schwab R
Sleep; 2020 Feb; 43(2):. PubMed ID: 31691827
[TBL] [Abstract][Full Text] [Related]
2. Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructive sleep apnea and narcolepsy.
Rosenberg R; Thorpy MJ; Dauvilliers Y; Schweitzer PK; Zammit G; Gotfried M; Bujanover S; Scheckner B; Malhotra A
J Clin Sleep Med; 2022 Jan; 18(1):235-244. PubMed ID: 34283019
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of solriamfetol on quality of life and work productivity in participants with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea.
Weaver TE; Pepin JL; Schwab R; Shapiro C; Hedner J; Ahmed M; Foldvary-Schaefer N; Strollo PJ; Mayer G; Sarmiento K; Baladi M; Bron M; Chandler P; Lee L; Malhotra A
J Clin Sleep Med; 2021 Oct; 17(10):1995-2007. PubMed ID: 34606437
[TBL] [Abstract][Full Text] [Related]
4. Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea.
Rosenberg R; Baladi M; Bron M
J Clin Sleep Med; 2021 Apr; 17(4):711-717. PubMed ID: 33226332
[TBL] [Abstract][Full Text] [Related]
5. Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.
Krystal AD; Benca RM; Rosenberg R; Schweitzer PK; Malhotra A; Babson K; Lee L; Bujanover S; Strohl KP
J Psychiatr Res; 2022 Nov; 155():202-210. PubMed ID: 36070638
[TBL] [Abstract][Full Text] [Related]
6. Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial.
Dauvilliers Y; Shapiro C; Mayer G; Lammers GJ; Emsellem H; Plazzi G; Chen D; Carter LP; Lee L; Black J; Thorpy MJ
CNS Drugs; 2020 Jul; 34(7):773-784. PubMed ID: 32588401
[TBL] [Abstract][Full Text] [Related]
7. Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial.
Schweitzer PK; Rosenberg R; Zammit GK; Gotfried M; Chen D; Carter LP; Wang H; Lu Y; Black J; Malhotra A; Strohl KP;
Am J Respir Crit Care Med; 2019 Jun; 199(11):1421-1431. PubMed ID: 30521757
[No Abstract] [Full Text] [Related]
8. Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study.
Strollo PJ; Hedner J; Collop N; Lorch DG; Chen D; Carter LP; Lu Y; Lee L; Black J; Pépin JL; Redline S;
Chest; 2019 Feb; 155(2):364-374. PubMed ID: 30471270
[TBL] [Abstract][Full Text] [Related]
9. A randomized study of solriamfetol for excessive sleepiness in narcolepsy.
Thorpy MJ; Shapiro C; Mayer G; Corser BC; Emsellem H; Plazzi G; Chen D; Carter LP; Wang H; Lu Y; Black J; Dauvilliers Y
Ann Neurol; 2019 Mar; 85(3):359-370. PubMed ID: 30694576
[TBL] [Abstract][Full Text] [Related]
10. Effects of solriamfetol in a long-term trial of participants with obstructive sleep apnea who are adherent or nonadherent to airway therapy.
Schweitzer PK; Strohl KP; Mayer G; Rosenberg R; Chandler P; Baladi M; Lee L; Malhotra A
J Clin Sleep Med; 2021 Apr; 17(4):659-668. PubMed ID: 33179591
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of solriamfetol for excessive sleepiness in narcolepsy and obstructive sleep apnea: findings from randomized controlled trials.
Wang J; Yang S; Li X; Wang T; Xu Z; Xu X; Gao H; Chen G
Sleep Med; 2021 Mar; 79():40-47. PubMed ID: 33472129
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials.
Subedi R; Singh R; Thakur RK; K C B; Jha D; Ray BK
Sleep Med; 2020 Nov; 75():510-521. PubMed ID: 33032062
[TBL] [Abstract][Full Text] [Related]
13. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
Ronnebaum S; Bron M; Patel D; Menno D; Bujanover S; Kratochvil D; Lucas E; Stepnowsky C
J Clin Sleep Med; 2021 Dec; 17(12):2543-2555. PubMed ID: 34402784
[TBL] [Abstract][Full Text] [Related]
14. Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment.
Schweitzer PK; Mayer G; Rosenberg R; Malhotra A; Zammit GK; Gotfried M; Chandler P; Baladi M; Strohl KP
Chest; 2021 Jul; 160(1):307-318. PubMed ID: 33631141
[TBL] [Abstract][Full Text] [Related]
15. Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy.
Emsellem HA; Thorpy MJ; Lammers GJ; Shapiro CM; Mayer G; Plazzi G; Chen D; Carter LP; Villa KF; Lee L; Menno D; Black J; Dauvilliers Y
Sleep Med; 2020 Mar; 67():128-136. PubMed ID: 31926465
[TBL] [Abstract][Full Text] [Related]
16. Solriamfetol for the Management of Excessive Daytime Sleepiness.
Cuomo MC; Sheehan AH; Jordan JK
J Pharm Pract; 2022 Dec; 35(6):963-970. PubMed ID: 33882756
[TBL] [Abstract][Full Text] [Related]
17. Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea.
Hoy SM
CNS Drugs; 2023 Nov; 37(11):1009-1020. PubMed ID: 37847434
[TBL] [Abstract][Full Text] [Related]
18. Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial.
Videnovic A; Amara AW; Comella C; Schweitzer PK; Emsellem H; Liu K; Sterkel AL; Gottwald MD; Steinerman JR; Jochelson P; Zomorodi K; Hauser RA
Mov Disord; 2021 Oct; 36(10):2408-2412. PubMed ID: 34191352
[TBL] [Abstract][Full Text] [Related]
19. Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study.
Ruoff C; Swick TJ; Doekel R; Emsellem HA; Feldman NT; Rosenberg R; Bream G; Khayrallah MA; Lu Y; Black J
Sleep; 2016 Jul; 39(7):1379-87. PubMed ID: 27166238
[TBL] [Abstract][Full Text] [Related]
20. Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea.
Powell J; Piszczatoski C; Garland S
Ann Pharmacother; 2020 Oct; 54(10):1016-1020. PubMed ID: 32270686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
